{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:13:18Z","timestamp":1791688398579,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1136\/ard.61.2.161","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:29:07Z","timestamp":1027765747000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment"],"prefix":"10.1016","volume":"61","author":[{"given":"C","family":"Ribbens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Martin y Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Franchimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-J","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Jaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F A","family":"Houssiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Malaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.2.161_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/art.1780370802","article-title":"Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?","volume":"37","author":"Vincenti","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1357-4310(97)01192-1","article-title":"Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases","volume":"4","author":"Cawston","year":"1998","journal-title":"Mol Med Today"},{"key":"10.1136\/ard.61.2.161_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/10454411930040020401","article-title":"Matrix metalloproteinases: a review","volume":"4","author":"Birkedal-Hansen","year":"1993","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1136\/ard.61.2.161_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj2480265","article-title":"Stromelysin is an activator of procollagenase","volume":"248","author":"Murphy","year":"1987","journal-title":"Biochem J"},{"key":"10.1136\/ard.61.2.161_bib5","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/S0021-9258(19)50563-4","article-title":"Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9","volume":"267","author":"Ogata","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.61.2.161_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02249017","article-title":"Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis","volume":"13","author":"Sasaki","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/ard.53.11.768","article-title":"Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity","volume":"53","author":"Taylor","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.61.2.161_bib8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/art.1780380713","article-title":"Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis","volume":"38","author":"Yoshihara","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/art.1780380803","article-title":"Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation","volume":"38","author":"Manicourt","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib10","first-page":"888","article-title":"Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis","volume":"27","author":"Ribbens","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib11","first-page":"1599","article-title":"Determination of stromelysin-1, 72 and 92 kDA type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis","volume":"23","author":"Ishiguro","year":"1996","journal-title":"J Rheumatol"},{"issue":"suppl","key":"10.1136\/ard.61.2.161_bib12","first-page":"S35","article-title":"Yttrium-90 synovectomy decreases circulating pro-metalloproteinase-3 in recurrent synovitis [abstract]","volume":"25","author":"Cheung","year":"1996","journal-title":"Rheumatology in Europe"},{"key":"10.1136\/ard.61.2.161_bib13","first-page":"251","article-title":"Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1\/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers","volume":"26","author":"Keyszer","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib14","first-page":"882","article-title":"High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis","volume":"27","author":"Cheung","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7","article-title":"Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis","volume":"43","author":"Yamanaka","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib16","first-page":"2329","article-title":"Elevated plasma stromelysin levels in arthritis","volume":"21","author":"Zucker","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib17","first-page":"409","article-title":"Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis","volume":"16","author":"Kotajima","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib18","first-page":"78","article-title":"Increased serum stromelysin-1 levels in systemic lupus erythematosus: lack of correlation with disease activity","volume":"26","author":"Zucker","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib19","first-page":"115","article-title":"Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis","volume":"95","author":"Akiyama","year":"1997","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1136\/ard.61.2.161_bib20","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/1529-0131(199807)41:7<1203::AID-ART9>3.0.CO;2-2","article-title":"Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis","volume":"41","author":"Sharif","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/39.12.1357","article-title":"Synovial fluid MMP-3 levels are increased in inflammatory arthritides whether erosive or not","volume":"39","author":"Ribbens","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.61.2.161_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/36.6.643","article-title":"Reduction of serum matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumor necrosis factor-\u03b1 (cA2) therapy","volume":"36","author":"Brennan","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib35","first-page":"105","article-title":"Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid","volume":"25","author":"Partsch","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/rheumatology\/31.3.201","article-title":"Ultrasonographic evidence of synovitis in axial joints in patients with polymyalgia rheumatica","volume":"31","author":"Koski","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.61.2.161_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ki.1997.310","article-title":"In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy","volume":"52","author":"Suzuki","year":"1997","journal-title":"Kidney Int"},{"key":"10.1136\/ard.61.2.161_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0046-8177(95)90253-8","article-title":"Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients","volume":"26","author":"Malide","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1136\/ard.61.2.161_bib40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/bj2960803","article-title":"Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumor necrosis factor-alpha, interleukin-1 and phorbol ester","volume":"296","author":"Hanemaaijer","year":"1993","journal-title":"Biochem J"},{"issue":"suppl 27","key":"10.1136\/ard.61.2.161_bib21","first-page":"10","article-title":"Criteria for classification of clinical osteoarthritis","volume":"18","author":"Altman","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.61.2.161_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondlylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib25","series-title":"Textbook of rheumatology","first-page":"1123","article-title":"Giant cell arteritis and polymyalgia rheumatica","author":"Hunder","year":"1997"},{"key":"10.1136\/ard.61.2.161_bib26","series-title":"Textbook of rheumatology","first-page":"999","article-title":"Psoriatic arthritis","author":"Gladmann","year":"1997"},{"key":"10.1136\/ard.61.2.161_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot Jr","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib32","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.2.161_bib33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.1780330808","article-title":"The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis","volume":"33","author":"Calabrese","year":"1990","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672409469X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672409469X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.2.161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:41:58Z","timestamp":1737243718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672409469X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S000349672409469X"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.2.161","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.2.161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}